Activist investors attempt to change the course at Radius Health, six months after two disappointing readouts
Following a disappointing data reveal and subsequent stock drop late last year, Radius Health is now facing an activist attack from two minority investors aiming to right the ship.
Velan Capital Investment Management and Repertoire Partners filed their proxy statements Tuesday morning in a bid to nominate a slate of three new board members at Radius’ annual shareholder meeting next month. The Velan-Repertoire group, which collectively owns a 7.7% stake, alleges Radius’ current directors have undertaken a bad commercial strategy for its one approved product and are unfit to serve because they own almost no shares in the company.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.